Professional Documents
Culture Documents
PDDBCBJJJJ 123
PDDBCBJJJJ 123
Introduction
yphoid (cloudy) fever is a systemic infection, caused
mainly by Salmonella typhi found only in man. It
is characterized by a continuous fever for 3-4 weeks,
relative bradycardia, with involvement of lymphoid
tissue and considerable constitutional symptoms. In
western countries, the disease has been brought very
close to eradication levels. In the UK, there is
approximately one case per 100,000 population per year.
Each year, the world over, there are at least 13-17 million
cases of typhoid fever, resulting in 600,000 deaths. 80%
of these cases and deaths occur in Asia alone. In South
East Asian nations, 5% or more of the strains of the
bacteria may already be resistant to several antibiotics
[1].
Antibiotics resistance, particularly emergence of
multidrug resistant (MDR) strains among Salmonellae
is also a rising concern and has recently been linked to
antibiotic use in livestock. Many S typhi strains contain
plasmids encoding resistance to chloramphenicol,
ampicillin and co-trimoxazole, the antibiotics that have
long been used to treat enteric fever. In addition,
resistance to ciprofloxacin also called nalidixic-acidresistant S typhi (NARST) strain either chromosomally
or plasmids encoded, has been observed in Asia. A
significant number of strains from Africa and the Indian
subcontinent are MDR type. A small percentage of
strains from Vietnam and the Indian subcontinent are
NARST strains [2].
The changing pattern of multi drug resistance in
typhoid fever was studied in Delhi in 1993 [3]. Out of
76 patients, 12 patients responded to a combination of
chloramphenicol and gentamicin, 51 to ciprofloxacin
while the remaining 9 responded to combination of
cefotaxime and amikacin. This study re-emphasizes
the changing pattern, and role of quinolone especially
ciprofloxacin in the management of drug resistant
typhoid fever, but at the same time indicates that
ciprofloxacin is not the drug of choice in all cases of
typhoid fever and resistance to it may be seen in some
cases, where other drugs have to be used.
Commandant, AMC Centre and School, Lucknow-2, +Associate Professor, Department of Medicine, #Professor and Head, Department of
Medicine, Armed Forces Medical College, Pune - 411 040, **Graded Specialist (Medicine), 12 Air Force Hospital, Gorakhpur.
131
Treatment
Supportive measures are important in the
management of typhoid fever, such as oral or
intravenous hydration, tepid bath and sponging and
appropriate nutrition and blood transfusions, if
indicated. More than 90% of patients can be managed
at home with oral antibiotics, a reliable caretaker, and
close medical follow-up for complications or failure to
respond to therapy.
Anti-microbial agents ( schedule of various
antibiotics is given in Table 1).
In the pre-antibiotic era, the mortality rate from
typhoid fever was as high as 15%. The introduction of
treatment with chloramphenicol in 1948 greatly altered
the disease course, decreasing mortality to <1% and
the duration of fever from 14-28 days to 3-5 days.
Chloramphenicol remained the standard treatment for
enteric fever until the emergence of plasmid-mediated
resistance to the drug in 1970s. A high relapse rate
(10-25%), a high rate of continued and chronic carriage,
bone marrow toxicity, and a high mortality rate in some
series from the developing world are other concerns
with chloramphenicol. Relapse may follow an
otherwise uneventful course and should be treated with
the same drug [2].
Given the increased mortality associated with
resistance to chloramphenicol and the rare
chloramphenicol-induced bone marrow toxicity,
ampicillin and trimethoprim-sulphamethoxazole (TMP-
Table 1
Anti-microbial therapy
Antibiotic
First-line antibiotics :
Chloramphenicol
Trimethoprim-Sulfamethoxazole
Ampicillin/Amoxycillin
Second-line antibiotics:
Fluoroquinolones
Ciprofloxacin
Norfloxacin
Pefloxacin
Ofloxacin
Cephalosporins
Ceftriaxone
Cefotaxime
Cefoperazone
Cefixime
Other antibiotics:
Aztreonam
Azithromycin
Route
Adult dosage/day
Dosage:mg/kg/day
Oral, IV
Oral, IV
Oral, IM, IV
500 mg qid
160/800 mg bid
1000-2000 mg qid
50 mg/kg in 4 doses @
4-20 mg/kg: in 2 doses
50-100 mg/kg: in 4 doses
14
14
14
Oral/IV
Oral
Oral, IV
Oral
500
400
400
400
NA
NA
NA
NA
10-14
10
10
14
IM, IV
IM, IV
IM, IV
Oral
1-2 gm bid
1-2 gm bid
1-2 gm bid
200-400 mg od/bid
7-10
14
14
14
IM
Oral
1 gm/bd-qid
1 gm od
5-7
5
mg
mg
mg
mg
bid/200 mg bid
bid
bid
bid
132
Kalra, et al
133
Daily dose
Route
Dose
Duration
(Days)
Ampicillin or
Amoxycillin + Probenicid
Co-trimoxazole
Ciprofloxacin
Norfloxacin
100 mg/kg
30 mg/kg
4-20 mg/kg
1500mg
800 mg
Oral
tid/qid
6-12 weeks
Oral
Oral
Oral
bid
bid
bid
6-12 weeks
4 weeks
4 weeks
134
Kalra, et al
Age
Vi CPS
Ty21 a, live
2 years
6 years
Route
Dosage
Revaccination
subcutaneous 0.5 ml
3 years
(0.25 ml for
children < 10y)
x 2 times,
4 weeks apart
subcutaneous 0.5 ml
3 years
oral
1 capsule
5 years
every other day,
total of 3 capsules
Conclusion
Management of typhoid fever continues to pose a
challenge, even one hundred years after the microorganism was first isolated by Gaffkey, a German in
1884. The absence of a reliable rapid diagnostic test,
will test the diagnostic skills of the treating physician.
A concerted effort involving clean water supply, sanitary
faeces disposal, effective vaccination and early
diagnosis and prompt treatment of cases and carriers
will be required to control the disease. Therapeutic
strategies will have to take into account the local
antibiotic sensitivity patterns of S typhi while defining
treatment.
References
1. WHO (1996). The World Health Report, Report of the Director
General WHO.
2. Miller SI, Peuges DA. Salmonella including Salmonella typhi.
In:Mandel GL, Raphael D. Editors, Principles and practice of
infectious diseases. 5th ed., Chruchill Livingstone 2000:234563.
3. Daga MK, Sarin K, Sarkar R. A study of culture positive
multidrug resistant enteric fever-changing pattern and emerging
resistance to ciprofloxacin. J Assoc Physicians India
1994;42(8):599-600.
4. Kabra SK. Multidrug-resistant typhoid fever. Trop
Doct.2000;30(4):195-7.
5. Das U. Multidrug resistant Salmonella typhi in Rourkela,
Orissa. Indian J Pathol Microbiol. 2000;43(2):135-8.
6. Tarr PE, Kuppens L, Jones TC, Ivanoff B, Aparin PG, Heymann
DL. Considerations regarding mass vaccination against typhoid
fever as an adjunct to sanitation and public health measures :
potential use in an epidemic in Tajikistan. Am J Trop Med
Hyg 1999;61:163-70.
26. Garcia JA, Damian RF. Typhoid fever. In : Rakel RE, Edward
MJAFI, Vol. 59, No. 2, 2003
135
ANNOUNCEMENT
BEST ARTICLE AWARD - MJAFI
With effect from 1994 all Original Articles published in MJAFI are being screened for selection of the
best two articles. These articles receive the Best Article Award and the Second Best Article Award.
They carry a cash prize of Rs.2000/- and Rs.1000/- respectively to be shared by all authors. Articles are
judged for their originality and research content.
So all those who believe that they have original work, not yet published, please send it in fast.
The following articles received the award for 2002 :
Best Article Award
Lt Col BK, Singh SM, Lt Col LC Pandey "Comprehensive surgical management of arthritic knee".
MJAFI;2002;58(1):18-22.
Second Best Article Award
Col BM Nagpal VSM, Surg Capt SK Mohanty SM, VSM, Col GL Tiwari VSM, Maj RPS Gambhir,
Brig Y Singh VSM "War Wounds - changing concepts". MJAFI;2002; 58(3): 192-5.